79
Views
0
CrossRef citations to date
0
Altmetric
Special Section: A Collection of Articles on Opportunities and Challenges in Utilizing Real-World Data for Clinical Trials and Medical Product Development

Good Data Science Practice: Moving toward a Code of Practice for Drug Development (Rejoinder)

ORCID Icon, , , ORCID Icon, &
Pages 89-91 | Received 15 Jul 2022, Accepted 06 Sep 2022, Published online: 07 Feb 2023

References

  • Baillie, M., Moloney, C., Mueller, C. P., Dorn, J., Branson, J., and Ohlssen, D. (2022), “Good Data Science Practice: Moving Toward a Code of Practice for Drug Development,” Statistics in Biopharmaceutical Research, 1–12, DOI: 10.1080/19466315.2022.2063172..
  • Boulesteix, A-L., Hoffmann, S., Charlton, A., and Seibold, H. (2020), “A Replication Crisis in Methodological Research?,” Significance (Oxford, England), 17, 18–21. DOI: 10.1111/1740-9713.01444.
  • Collins, R., Bowman, L., Landray, M., and Peto, R. (2020), “The Magic of Randomization versus the Myth of Real-World Evidence,” The New England Journal of Medicine, 382, 674–678. DOI: 10.1056/NEJMsb1901642.
  • Cornelius, V. R., and Phillips, R. (2022), “Improving the Analysis of Adverse Event Data in Randomized Controlled Trials,” Journal of Clinical Epidemiology, 144, 185–192. DOI: 10.1016/j.jclinepi.2021.12.023.
  • Diaconis, P. (2011), “Theories of Data Analysis: From Magical Thinking through Classical Statistics,” in Exploring Data Tables, Trends, and Shapes, eds. D. C. Hoaglin, F. Mosteller, and J. W. Tukey, pp. 1–36, Hoboken, NJ: Wiley. DOI: 10.1002/9781118150702.ch1..
  • Donoho, D. (2017), “50 Years of Data Science,” Journal of Computational and Graphical Statistics, 26, 745–766. DOI: 10.1080/10618600.2017.1384734..
  • Fang, Y., and He, W. (2022), Comment on “Good Data Science Practice: Moving Towards a Code of Practice for Drug Development,” Statistics in Biopharmaceutical Research, 1–6, DOI: 10.1080/19466315.2022.2090432..
  • Hernán, M. A., Hsu, J., and Healy, B. (2019), “A Second Chance to Get Causal Inference Right: A Classification of Data Science Tasks,” CHANCE, 32, 42–49. DOI: 10.1080/09332480.2019.1579578.
  • Ho, M., van der Laan, M., Lee, H., Chen, J., Lee, K., Fang, Y., He, W., Irony, T., Jiang, Q., Lin, X., Meng, Z., Mishra-Kalyani, P., Rockhold, F., Song, Y., Wang, H., and White, R. (2021), “The Current Landscape in Biostatistics of Real-World Data and Evidence: Causal Inference Frameworks for Study Design and Analysis,” Statistics in Biopharmaceutical Research, 1–14, DOI: 10.1080/19466315.2021.1883475..
  • International Conference on Harmonisation (2018), “ICH E9 Statistical Principles for Clinical Trials.” September 17, 2018. Available at https://www.ema.europa.eu/en/ich-e9-statistical-principles-clinical-trials.
  • Krieger, N., and Davey Smith, G. (2016), “The Tale Wagged by the DAG: Broadening the Scope of Causal Inference and Explanation for Epidemiology,” International Journal of Epidemiology, 45, 1787–1808. DOI: 10.1093/ije/dyw114.
  • Laan, M. V D., Hubbard, A., Coyle, J., Hejazi, N., Malenica, I., and Phillips, R. n.d. “Chapter 2 The Targeted Learning Roadmap.” Accessed June 29, 2022. Available at https://tlverse.org/acic2019-workshop/intro.html.
  • Lawlor, D. A., Tilling, K., and Davey Smith, G. (2016), “Triangulation in Aetiological Epidemiology,” International Journal of Epidemiology, 45, 1866–1886.
  • Ruberg, S. J., Harrell, F. E., Jr.,Gamalo-Siebers, M., LaVange, L., Jack Lee, J., Price, K., and Peck, C. (2019), “Inference and Decision Making for 21st-Century Drug Development and Approval,” The American Statistician, 73, 319–327. DOI: 10.1080/00031305.2019.1566091.
  • Sheiner, L. B. (1997), “Learning versus Confirming in Clinical Drug Development,” Clinical Pharmacology and Therapeutics, 61, 275–291. DOI: 10.1016/S0009-9236(97)90160-0.
  • Stodden, V. (2020), “The Data Science Life Cycle: A Disciplined Approach to Advancing Data Science as a Science,” Communications of the ACM, 63, 58–66. DOI: 10.1145/3360646.
  • Tong, C. (2019), “Statistical Inference Enables Bad Science; Statistical Thinking Enables Good Science,” The American Statistician, 73, 246–261. DOI: 10.1080/00031305.2018.1518264.
  • Tukey, J. W. (1980), “We Need both Exploratory and Confirmatory,” The American Statistician, 34, 23–25.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.